< back to news
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2011

KAILUA KONA, Hawaii (February 11, 2011) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the third quarter and first nine months of fiscal 2011, ended December 31, 2010.

Third Quarter 2011
For the third quarter of fiscal 2011 compared to the third quarter of fiscal 2010, revenues were $3,919,000 compared to revenues of $3,982,000. Gross profit was $1,232,000, with gross profit margin of 31%, compared to gross profit of $1,750,000 and gross profit margin of 44%. Net income was $10,000, or $0.00 per diluted share, compared to $605,000, or $0.11 per diluted share.

Trailing 12 Months
For the trailing 12 months ended December 31, 2010, compared to the trailing 12 months ended December 31, 2009, revenues were $15,423,000 compared to revenues of $15,350,000. Gross profit was $5,931,000, with gross profit margin of 38%, compared to gross profit of $6,509,000 and gross profit margin of 42%. Net income was $709,000, or $0.14 per diluted share, compared to $1,811,000, or $0.35 per diluted share.

“Trends of our new marketing initiatives continued to improve in the third quarter of fiscal 2011, although overall sales were down 2%,” said Brent Bailey, President and CEO. “Sales of Cyanotech’s branded, higher-margin packaged products, a core initiative, increased 25% for Spirulina and 40% for natural Astaxanthin, offset by lower private label sales for both products. Marketing and sales expense increased by 49% from the third quarter of fiscal 2010 to support new brokers and broker training as well as new marketing programs for packaged products.”

“Our third quarter fiscal 2011 production was well below the same period in fiscal 2010 due to several factors including rain events and the subsequent recovery time to normal production levels,” Bailey added. “These factors were the primary driver of our margin decline for the quarter and are not expected to continue.”

“Cyanotech makes products that can favorably impact many of our most significant global health issues. Spirulina is nutrition in its most concentrated form and natural Astaxanthin is the world’s most powerful known natural antioxidant. In my opinion, these two products are the best kept secret in the nutritional supplement industry. We intend to change that and build them to their full potential,” noted Bailey.

Cash and cash equivalents were $729,000 at December 31, 2010 compared to the March 31, 2010 balance of $817,000. Working capital was $5,944,000 at December 31, 2010 compared to $4,942,000 at March 31, 2010.

For the third quarter of fiscal 2011 compared to the third quarter of fiscal 2010, Spirulina sales accounted for 46% of total revenues and natural Astaxanthin sales for 54%. International sales were 44% of total sales.

First Nine Months 2011
For the first Nine months of fiscal 2011 compared to the first nine months of fiscal 2010, revenues were $11,609,000 compared to revenues of $11,928,000. Gross profit was $4,543,000, with gross profit margin of 39%, compared to gross profit of $5,245,000 and gross profit margin of 44%. Net income was $935,000, or $0.17 per diluted share, compared to $1,617,000, or $0.30 per diluted share.

About CyanotechCyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.

“Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995 Besides statements of present fact and historical fact, this press release may contain forward-looking statements. Forward-looking statements relate to the future and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by forward-looking statements. We caution against relying on forward-looking statements. Important factors that could change actual, future results include: changes in sales levels to our largest customers, weather patterns in Hawaii, production problems, risks associated with new products, foreign exchange fluctuations, and availability of financing, as well as national and global political, economic, business, competitive, market and regulatory conditions. Other factors are more fully detailed in the Company’s recent Form 10-Q and annual Form 10-K filings with the Securities and Exchange Commission.

(Financial Tables Follow: The following tables do not contain footnotes or other information contained in the Company’s Form 10-Q for the period ended December 31, 2010. As such the following Financial Tables are provided only as a guide and other factors are more fully detailed in the Company’s Form 10-Q and annual Form 10-K filings with the Securities and Exchange Commission.)

Contact:
Bruce Russell: brussell@cyanotech.com
(310) 559-4955 x101



 

 
 
 
Home About CyanotechContact UsSign up for News © 2012 Cyanotech Corporation